Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

ReCode Therapeutics Stock

recodetx.comHealthcareFounded: 2015Funding to Date: $323.57MM

Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.

Buy or sell ReCode Therapeutics stock Learn more about ReCode Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for ReCode Therapeutics.

Register Today

Other companies like ReCode Therapeutics in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions